Intervention Review

You have free access to this content

Dopamine agents for hepatic encephalopathy

  1. Anders Ellekær Junker1,*,
  2. Bodil Als-Nielsen2,
  3. Christian Gluud3,
  4. Lise Lotte Gluud4

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 10 FEB 2014

Assessed as up-to-date: 13 JAN 2014

DOI: 10.1002/14651858.CD003047.pub3


How to Cite

Junker AE, Als-Nielsen B, Gluud C, Gluud LL. Dopamine agents for hepatic encephalopathy. Cochrane Database of Systematic Reviews 2014, Issue 2. Art. No.: CD003047. DOI: 10.1002/14651858.CD003047.pub3.

Author Information

  1. 1

    Gentofte Hospital, Department of Medicine F, Hellerup, Denmark

  2. 2

    The Child and Youth Clinic, Department of Paediatric Haematology/Oncology (5054), Copenhagen, Denmark

  3. 3

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, The Cochrane Hepato-Biliary Group, Copenhagen, Denmark

  4. 4

    Copenhagen University Hospital Hvidovre, Gastro Unit, Medical Division, Hvidovre, Denmark

*Anders Ellekær Junker, Department of Medicine F, Gentofte Hospital, Niels Andersens Vej 65, Hellerup, 2900, Denmark. andjunker@dadlnet.dk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 10 FEB 2014

SEARCH